Page 260 - Drug Class Review
P. 260
Page 160 of 205
Drug Effectiveness Review Project
Alzheimer Drugs Authors: Cutler et al. 81 Year: 1998 NR Study design: Pooled data analysis Number of patients: 3,350 To determine the incidence rates of adverse events for TAC, DON, and RIV NR NR RCTs NR
Final Report Update 1 Adverse Events STUDY: FUNDING: DESIGN: AIMS OF REVIEW: STUDIES INCLUDED IN REVIEW TIME PERIOD COVERED: CHARACTERISTICS OF INCLUDED STUDIES: CHARACTERISTICS OF INCLUDED POPULATIONS: Alzheimer's Drugs
